Dr. Reddy's Laboratories Ltd. (RDY)
Market Closed
12 Jun, 20:00
$
13. 30
-0.06
-0.4491%
$
11.07B Market Cap
18.96 P/E Ratio
0.49% Div Yield
1.17M Volume
3.76 Eps
$ 13.36
Previous Close Want to track RDY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Dr. Reddy's (RDY) Q1 Earnings Miss Estimates, Revenues Beat
Dr. Reddy's (RDY) reports mixed first-quarter fiscal 2025 results, wherein earnings lag estimates, but revenues beat the same, driven by growth in global generics sales in North America and India.
Zacks | 1 year ago
Dr. Reddy's (RDY) to Acquire Haleon's Nicotine Addiction Drug
Dr. Reddy's (RDY) is set to acquire Haleon's leading global NRT brand, Nicotinell, and its related portfolio across all formats of the drug for GBP 500 million to boost its OTC presence worldwide.
Zacks | 1 year ago
Dr. Reddy's (RDY), Alvotech Unite for Prolia & Xgeva Biosimilar
Dr. Reddy's (RDY) announces entering into a license and supply agreement with Alvotech to develop and commercialize the latter's biosimilar candidate, AVT03, to Prolia and Xgeva.
Zacks | 2 years ago
